[1] Pearlstein T, Yonkers KA, Fayyad R, Gillespie JA. Pretreatment pattern of
symptom expression in premenstrual dysphoric disorder. J Affect Disord
2005;85:275e82.
[2] Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression
across the female life cycle: a continuum of vulnerability? J Psychiatry Neurosci 2008;33:331e43.
[3] Steiner M, Macdougall M, Brown E. The premenstrual symptoms screening
tool (PSST) for clinicians. Arch Womens Ment Health 2003;6:203e9.
[4] Wittchen HU, Becker E, Lieb R, Krause P. Prevalence, incidence and stability of
premenstrual dysphoric disorder in the community. Psychol Med 2002;32:
119e32.
[5] Cohen LS, Miner C, Brown EW, Freeman E, Halbreich U, Sundell K, et al. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebocontrolled, clinical trial using computerized diaries. Obstet Gynecol
2002;100:435e44.
[6] Sternfeld B, Swindle R, Chawla A, Long S, Kennedy S. Severity of premenstrual
symptoms in a health maintenance organization population. Obstet Gynecol
2002;99:1014e24.
[7] Dennerstein L, Lehert P, Heinemann K. Epidemiology of premenstrual symptoms and disorders. Menopause Int 2012;18(2):48e51.
[8] Lee YJ, Yi SW, Ju DH, Lee SS, Sohn WS, Kim IJ. Correlation between postpartum
depression and premenstrual dysphoric disorder: single center study. Obstet
Gynecol Sci 2015;58:353e8.
[9] Buttner MM, Mott SL, Pearlstein T, Stuart S, Zlotnick C, O'Hara MW. Examination of premenstrual symptoms as a risk factor for depression in postpartum women. Arch Womens Ment Health 2013;16:219e25.
[10] Keppel AL, Lee EE, Haq N, Rubinow DR, Schmidt PJ. History of postpartum
depression in a clinic-based sample of women with premenstrual dysphoric
disorder. J Clin Psychiatry 2016;77. e4 15-20.
[11] Cox JL, Holden JM, Sagovsky R. Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry
1987;150:782e6.
[12] Okano T, Murata M, Masuji F, Tamaki R, Nomura J, Miyaoka H, et al. Validation
and reliability of Japanese version of the EPDS. Arch Psychiatr Diagn Clin Eval
1996;7:525e33 [published in Japanese].
[13] Bloch M, Rotenberg N, Koren D, Klein E. Risk factors associated with the
development of postpartum mood disorders. J Affect Disord 2005;88:9e18.
[14] Bloch M, Rotenberg N, Koren D, Klein E. Risk factors for early postpartum
depressive symptoms. Gen Hosp Psychiatry 2006;28:3e8.
[15] Bloch M, Daly RC, Rubinow DR. Endocrine factors in the etiology of postpartum depression. Compr Psychiatry 2003;44:234e46.
[16] Klink R, Robichaud M, Debonnel G. Gender and gonadal status modulation of
dorsal raphe nucleus serotonergic neurons. Part I: effects of gender and
pregnancy. Neuropharmacology 2002;43:1119e28.
[17] Sacher J, Wilson AA, Houle S, Rusjan P, Hassan S, Bloomfield PM, et al. Elevated
brain monoamine oxidase A binding in the early postpartum period. Arch Gen
Psychiatry 2010;67:468e74.
[18] Pearlstein T, Steiner M. Premenstrual dysphoric disorder: burden of illness
and treatment update. J Psychiatry Neurosci 2008;33:291e301.
[19] Ryu A, Kim TH. Premenstrual syndrome: a mini review. Maturitas 2015;82:
436e40.
[20] Perkonigg A, Yonkers KA, Pfister H, Lieb R, Wittchen HU. Risk factors for
premenstrual dysphoric disorder in a community sample of young women:
the role of traumatic events and posttraumatic stress disorder. J Clin Psychiatry 2004;65:1314e22.
[21] Cohen LS, Soares CN, Otto MW, Sweeney BH, Liberman RF, Harlow BL. Prevalence and predictors of premenstrual dysphoric disorder (PMDD) in older
premenopausal women. The Harvard Study of Moods and Cycles. J Affect
Disord 2002;70:125e32.
...